Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Precision for Medicine

Precision for Medicine

Jan 22, 2020

M&A Deals in MDx/Omics Research Tools Space Up 13 Percent in 2019

Premium

Although Illumina's failure to acquire Pacific Biosciences stood out in 2019, the upward trend in M&A activity in the omics space in 2018 continued last year.

Nov 05, 2019

Akoya Biosciences, Precision for Medicine to Develop Liquid Biopsy, Tissue Biomarker Tests

The team will combine Akoya's Vectra Polaris system with Precision for Medicine's Apostream tool to validate companion diagnostics and assess drug efficacy. 

Aug 01, 2019

Precision for Medicine Acquires Biospecimen Providers ProMedDx, GLAS

The deals follow a pair of other recent acquisitions by Precision for Medicine in the artificial intelligence technology and biomarker analysis fields.

Mar 06, 2019

Precision for Medicine Acquires AI Developer SimplicityBio

With the acquisition of Swiss healthcare AI specialist SimplicityBio, Precision for Medicine can offer new features in its QuartzBio multiomic data integration platform.

Jan 02, 2019

Circulating Tumor Cell Capture Technologies Expand in 2018

Premium

Research groups and companies are developing and applying tools to enrich for and capture CTCs to diagnose tumors early and monitor patients during treatment.

Oct 16, 2018

Precision for Medicine Acquires ApoCell

The move will gain PFM a Houston lab, as well as ApoCell's proprietary ApoStream liquid biopsy technology for isolation and capture of circulating tumor cells.

Oct 04, 2017

Precision for Medicine Buys Immune Monitoring Lab Epiontis

The deal provides Precision for Medicine with a proprietary PCR-based technology that amplifies and detects euchromatic DNA expressed exclusively by cell types of interest.

Mar 22, 2016

Precision for Medicine to Acquire ACT Oncology

The deal joins Precision for Medicine's suite of biomedical research tools and services with ACT Oncology's expertise in clinical study design and execution.

Mar 19, 2015

Precision for Medicine Launches PATH to Help Stratify Patients for Personalized Medicine Studies

Premium

PATH is designed to help users combine and use clinical and genomic information to stratify patients as part of efforts to develop more tailored therapies.

Apr 16, 2009

Mass Spec Chief Execs See Rise in 2008 Salaries, but Overall Compensation Shrinks

Premium

CEOs at four of the five leading mass spec firms saw their total compensation dip last year, according to information provided in their proxy statements, with Bill Sullivan at Agilent taking the biggest hit, a 39 percent drop from his 2007 earnings. Meanwhile, Frank Laukien at Bruker received an 80 percent upgrade in 2008.

The Scan

COVAX's First Shipment

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

Support for Another

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

New Prototype Test

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

Cell Studies on SARS-CoV-2 Spike Variant, Host Transcriptomes, Glioma-Infiltrating T Cells

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.